BRIEF published on 05/27/2025 at 15:40, 6 months 8 days ago HENSOLDT AG Reviews 2025 Annual General Meeting Voting Results HENSOLDT AG Supervisory Board Elections Dividend Approval 2025 AGM
PRESS RELEASE published on 05/27/2025 at 15:35, 6 months 8 days ago 2025 Annual General Meeting: HENSOLDT gives positive review HENSOLDT AG successfully held its 2025 Annual General Meeting in Munich with majority approval on agenda items. See detailed voting results here Annual General Meeting Shareholders Voting Results HENSOLDT Approval
BRIEF published on 05/07/2025 at 07:35, 6 months 28 days ago HENSOLDT Reports Strong First Quarter 2025 Results Order Intake Growth Revenue Rise HENSOLDT Financials Optronics Segment Defense Investment
PRESS RELEASE published on 05/07/2025 at 07:30, 6 months 28 days ago HENSOLDT reports strong first quarter 2025 with growth in order intake and revenue HENSOLDT reports strong first quarter 2025 with growth in order intake and revenue. Order backlog at new record level. Financial restructuring completed. Guidance for 2025 confirmed Revenue Growth Order Intake HENSOLDT Financial Restructuring Financial Year 2025
BRIEF published on 03/27/2025 at 07:35, 8 months 8 days ago HENSOLDT Achieves Robust Growth in 2024 HENSOLDT Annual Report 2024 Defense Electronics Software Defined Defence Geopolitical Strategy
PRESS RELEASE published on 03/27/2025 at 07:30, 8 months 8 days ago HENSOLDT continues growth path in 2024 HENSOLDT achieved profitable growth in 2024, solidifying its position as a key player in European defence electronics. The annual report highlights success factors and future strategies amid evolving geopolitical challenges Geopolitical Challenges Annual Report Profitable Growth HENSOLDT Defence Electronics
BRIEF published on 02/27/2025 at 07:35, 9 months 5 days ago HENSOLDT Reports Record Order Backlog for 2024 Revenue Increase Profitability Order Backlog Financial Growth Defence Electronics
PRESS RELEASE published on 02/27/2025 at 07:30, 9 months 5 days ago HENSOLDT achieves record order backlog in financial year 2024 – guidance for all key figures met, partly exceeded HENSOLDT achieves record order backlog in financial year 2024, meeting and exceeding key figures guidance. Order intake at EUR 2.9 billion, revenue at EUR 2.24 billion Financial Results Revenue Growth HENSOLDT Record Order Backlog Guidance Met
BRIEF published on 12/12/2024 at 07:35, 11 months 23 days ago HENSOLDT Unveils Expanded EBITDA Targets and New Strategic Growth Plan Growth Strategy HENSOLDT EBITDA Targets Defence Market North Star
PRESS RELEASE published on 12/12/2024 at 07:30, 11 months 23 days ago HENSOLDT raises medium-term EBITDA target and presents new growth strategy HENSOLDT raises medium-term EBITDA target and presents new growth strategy at Capital Markets Day. Company aims for 10% annual revenue growth and 20% EBITDA margin in medium term Growth Strategy EBITDA Revenue Growth Capital Markets Day HENSOLDT
Published on 12/05/2025 at 02:35, 3 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 14 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
